CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ARQT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,855,795
-$5,614,752 QoQ
Shares Held
1,012,555
-0.2% QoQ
Ownership
0.810%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. ARQT ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ARQT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,855,795 | 1,012,555 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,470,547 | 1,014,826 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,839,330 | 999,434 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,530,225 | 965,066 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,462,411 | 860,768 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $12,241,739 | 878,804 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,996,567 | 859,846 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,917,313 | 851,324 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,439,674 | 750,724 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,845,357 | 571,318 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,038,047 | 383,813 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,144,347 | 329,942 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,327,522 | 302,502 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,465,574 | 301,728 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,562,787 | 291,093 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,629,810 | 217,260 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,870,566 | 200,964 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,115,915 | 198,453 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,678,545 | 195,837 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,277,394 | 193,382 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,198,142 | 179,680 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,978,679 | 141,439 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,241,253 | 110,623 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,063,759 | 68,246 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $656,225 | 22,021 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||